T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.26% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
UDR
UDR
$12.2B
| $21.3M | ﹤0.01% |
583,502
+45,987
| +9% | +$2.08M |
|
1052
Rocket Pharmaceuticals
RCKT
$367M
| $21.3M | ﹤0.01% |
1,527,758
-325,912
| -18% | -$6.45M |
|
1053
Oil-Dri
ODC
$1.27B
| $21.3M | ﹤0.01% |
1,271,080
-133,524
| -10% | -$2.29M |
|
1054
Denali Therapeutics
DNLI
$3.97B
| $21.2M | ﹤0.01% |
1,211,039
+793,883
| +190% | +$16.6M |
|
1055
Zai Lab
ZLAB
$2.92B
| $21.2M | ﹤0.01% |
411,673
+28,974
| +8% | +$1.51M |
|
|
NEX
1056
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $21.1M | ﹤0.01% |
18,076,239
+5,902,874
| +48% | +$25.9M |
|
1057
Lincoln Electric
LECO
$15.5B
| $21.1M | ﹤0.01% |
306,449
-2,425
| -0.8% | -$208K |
|
1058
Insperity
NSP
$2.05B
| $21.1M | ﹤0.01% |
565,397
-114,702
| -17% | -$8.14M |
|
|
CIR
1059
DELISTED
CIRCOR International, Inc
CIR
| $21.1M | ﹤0.01% |
1,810,811
+63,529
| +4% | +$2.24M |
|
1060
Red Robin
RRGB
$183M
| $20.9M | ﹤0.01% |
2,454,639
+93,582
| +4% | +$2.45M |
|
1061
APA Corp
APA
$14B
| $20.9M | ﹤0.01% |
4,995,675
-1,037,551
| -17% | -$23.1M |
|
1062
RenaissanceRe
RNR
$13.3B
| $20.9M | ﹤0.01% |
139,761
-33,022
| -19% | -$5.88M |
|
1063
Gaotu Techedu
GOTU
$401M
| $20.7M | ﹤0.01% |
489,245
-759,298
| -61% | -$28M |
|
|
ECOL
1064
DELISTED
US Ecology, Inc.
ECOL
| $20.7M | ﹤0.01% |
680,495
+111,746
| +20% | +$5.17M |
|
|
GRMN
1065
Garmin
GRMN
$60.2B
| $20.7M | ﹤0.01% |
275,762
+22,521
| +9% | +$2.04M |
|
1066
National Fuel Gas
NFG
$7.75B
| $20.6M | ﹤0.01% |
553,641
+489,061
| +757% | +$20M |
|
1067
Hilton Grand Vacations
HGV
$3.49B
| $20.6M | ﹤0.01% |
1,307,454
-13,750
| -1% | -$378K |
|
1068
National CineMedia
NCMI
$252M
| $20.6M | ﹤0.01% |
631,834
+529,426
| +517% | +$34.5M |
|
1069
Kirby Corp
KEX
$7.26B
| $20.6M | ﹤0.01% |
473,328
-35,449
| -7% | -$2.41M |
|
1070
TherapeuticsMD
TXMD
$24.1M
| $20.5M | ﹤0.01% |
387,211
+2,420
| +0.6% | +$240K |
|
|
HBI
1071
DELISTED
Hanesbrands
HBI
| $20.5M | ﹤0.01% |
2,606,857
+1,966,730
| +307% | +$24.9M |
|
1072
Huron Consulting
HURN
$2.47B
| $20.4M | ﹤0.01% |
450,084
-735,974
| -62% | -$44.4M |
|
|
PGNX
1073
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $20.3M | ﹤0.01% |
5,342,927
+352,137
| +7% | +$1.52M |
|
|
MDLA
1074
DELISTED
Medallia, Inc.
MDLA
| $20.3M | ﹤0.01% |
1,012,683
-595,174
| -37% | -$16M |
|
1075
Ventas
VTR
$46.3B
| $20.2M | ﹤0.01% |
754,512
+58,625
| +8% | +$2.91M |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.